Nesiritide for outpatient treatment of heart failure

被引：0

作者：

Bauer, EB ^{[1
]}

Randazzo, MA ^{[1
]}

机构：

[1] St Elizabeth Hosp, Belleville, IL 62234 USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2005年 / 62卷 / 24期

关键词：

D O I：

10.2146/ajhp050199

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Although outpatient care has become vital in the management of chronic heart failure, no study has shown that nesiritide contributes safely to that care. The authors of this commentary recommend that, until nesiritide's safety profile in outpatients has been defined, the drug should be used only in inpatients whose acute decompensated heart failure has not responded to adequate attempts with diuretics and vasodilators.

引用

页码：2639 / 2642

页数：4

共 50 条

[31] Nesiritide (Natrecor) for acute decompensated heart failure
Shatsky, M
AMERICAN FAMILY PHYSICIAN, 2006, 73 (04) : 687 - 688
[32] Initial experience with nesiritide in pediatric heart failure
Mahle, WT
Cuadrado, A
Kirshbom, PM
Kanter, KR
Simsic, JM
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 315A - 315A
[33] Safety and efficacy of nesiritide in pediatric heart failure
Jefferies, John L.
Price, Jack F.
Denfield, Susan W.
Chang, Anthony C.
Dreyer, William J.
Mcmahon, Colin J.
Grenier, Michelle A.
Clunie, Sarah K.
Thomas, Anne
Moffett, Brady S.
Wann, Tiffany S.
Smith, E. O'Brian
Towbin, Jeffrey A.
JOURNAL OF CARDIAC FAILURE, 2007, 13 (07) : 541 - 548
[34] Nesiritide - The latest drug for treating heart failure
Fontana, D
CRITICAL CARE NURSE, 2006, 26 (01) : 39 - +
[35] Benefit-Risk Assessment of Nesiritide in the Treatment of Acute Decompensated Heart Failure
Clyde W. Yancy
Drug Safety, 2007, 30 : 765 - 781
[36] Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure
Yancy, Clyde W.
DRUG SAFETY, 2007, 30 (09) : 765 - 781
[37] Nesiritide in Acute Decompensated Heart Failure REPLY
O'Connor, Christopher M.
Hernandez, Adrian F.
Califf, Robert M.
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (16): : 1547 - 1547
[38] Safety and Efficacy of Outpatient Nesiritide in Patients With Advanced Heart Failure Results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) Trial
Yancy, Clyde W.
Krum, Henry
Massie, Barry M.
Silver, Marc A.
Stevenson, Lynne Warner
Cheng, Mei
Kim, Sun Sook
Evans, Rosemary
CIRCULATION-HEART FAILURE, 2008, 1 (01) : 9 - 16
[39] Controversy and conflict in the treatment of acute decompensated heart failure: Nesiritide as evidence-based treatment
Munger, Mark A.
Ng, Tien M. H.
Van Tassell, Benjamin W.
PHARMACOTHERAPY, 2007, 27 (05): : 619 - 625
[40] Impact of nesiritide on diastolic dysfunction in advanced heart failure
Bhaskaran, Ambika
Siegel, Robert M.
Vermillion, Jennifer C.
Barker, Barbara
Garg, Ashok
John, Tracey
Romo, James
JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S127 - S127

← 1 2 3 4 5 →